miRNA exon-skipping antisense oligonucleotides (Rosetta Genomics/Marina Biotech)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamemiRNA exon-skipping antisense oligonucleotides (Rosetta Genomics/Marina Biotech)
Drug Alias NamemiRNA外显子跳跃反义寡核苷酸（Rosetta Genomics / Marina Biotech）
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesRosetta GenomicsMarina Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRosetta GenomicsMarina Biotech
Active IndicationsN/A
Inactive IndicationsMuscular Dystrophy, Duchenne

Other Information

ATC CodeN/A
Related LinksN/A